12.04.2018 Issue 430

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

Pharmerit Lays Out Key Steps
in RWE Generation Plan

Monday, December 3

Developing a robust strategy to address RWE needs early in the pre-launch phase for drugs, diagnostic agents and medical devices is key to “seamless integration of health economics and outcomes research to support product value and market access,” Pharmerit’s Shelby Corman writes.

Report: Environment More Friendly to OBCs

Amazon Grapples with Licensing Challenges

ICER Provides Policy Recommendations for Opioid Use Disorder Therapies

CVS Caremark Pushes Forward with QALYs Despite Patient Groups’ Criticism

Some Employers Taking Active Steps to Curb Health Costs

Course to Focus on Better Use of RWE in Outcomes Measurements, Innovation Evaluation

DIA 2019 Offering Series of Short Courses

After Midterms, Door Opens for Bipartisan Action on Drug Pricing

IBM Watson Health to host Webinar on Value, Access

Researcher - HEOR

Executive Director, Health Technology Assessment (HTA) Statistics (U.S.)

Executive Director, Health Technology Assessment (HTA) Statistics (U.K.)

Associate Director, Health Economics & Outcomes Research

Industry Spotlight

Conferences Webinars
Principles of Pharma Market Access in Europe
    December 4-5, Brussels, Belgium

Bio/Pharma Compliance Congress on Non-Promotional Activities
    December 4-5, Philadelphia, Pennsylvania

Value Pricing for Market Access
    December 6-7, Brussels, Belgium

15th Clinical Performance Metrics Summit
    December 6-7, Philadelphia, Pennsylvania

14th Annual Trade and Channel Strategies
    December 11-12, Philadelphia, Pennsylvania

Population-based Care Management: How Health Plans Can Leverage PHM Solutions for Value-based Care (Part II)
    December 6

Right-to-Try or Right-to-Ask? Understanding Right-to-Try and FDA’s Expanded Access
    December 11

Intelligent Approaches to Transform Value and Access
    December 12

Managing Challenging Long-term Services and Supports Patients to Improve Care and Reduce Costs
    December 13

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs, Biologics

Blockchain: Transformational Change for Pharma?

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Transitioning Payment Models: Fee-for-Service to Value-Based Care

How Health Plans and Providers Can Collaborate to Improve Care Transitions and Reduce Hospital Readmissions

Generating Consensus and Trust for Quality Measurement to Support Value-Based Care

An Evidence-Based Approach to Hiring: Leaders, Physicians, Nurses, and Front Line Staff

Big Data in Pharmaceuticals: Big Opportunities or Big Challenges – or Both?

AHIP Executive Roundtable Discussion Summary

Special Thanks to Our Partners:
Evidera   HealthCore     University of FL  Xcenda   OM1
Parexel   Jefferson   Dymaxium   Precision Xtract    Pharmerit
    eMax Health   Sciformix   Evidence Partners   
ICON    Truven    
Share this newsletter on social media:

Email Twitter Facebook LinkedIn